Biocon’s Yesintek gains market entry into nine high-growth markets, expanding its global biosimilar reach through a settlement with Janssen Sciences Ireland.
AIG Hospitals and Boston Scientific are expanding specialist training to support access to advanced gastrointestinal procedures beyond major Indian cities.
A KGMU report highlights gaps in breast cancer screening follow-up in Uttar Pradesh, raising concerns about timely diagnosis and access to care.
India has come a long way in the management of cardiovascular disease. With advances in diagnostics, interventional cardiology and cardiac surgery, patients with complex heart conditions have more options than ever before. However, access to newer su
If you stand at a chemist counter in Delhi for half an hour, you'll notice something. A good share of what people ask for is skin related: a cream for a rash that won't go
Roche’s next-generation drug divarasib cuts lung cancer death risk by 44%, offering longer survival and improved treatment tolerability.
CLDN18.2 testing is gaining attention as AstraZeneca's experimental stomach cancer drug shows survival benefits, potentially widening eligibility for targeted treatment among patients.
NAPCON 2026 highlights how artificial intelligence can support early detection of tuberculosis and lung cancer through advanced medical imaging.
AIIMS Nagpur secures Rs 30 crore for a Biosafety Level III laboratory, strengthening Maharashtra’s pathogen detection and infectious disease preparedness.
Novartis' Remibrutinib data highlight new findings on relapse reduction, disability progression and the potential role of oral therapies in multiple sclerosis.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
